A pain-causing and paralytic ant venom glycopeptide
Samuel D. Robinson(The University of Queensland), Eivind A. B. Undheim(The University of Queensland), Angelo Keramidas(The University of Queensland), Andrew A. Walker(The University of Queensland), Hannes Hinneburg(Macquarie University), Richard J. Payne(The University of Sydney), Sameer S. Kulkarni(The University of Sydney), Leo Corcilius(The University of Sydney), Alun Jones(Imperial College London), Alexander Mueller(Princeton University), Lucas Kambanis(The University of Sydney), Morten Thaysen‐Andersen, Irina Vetter(Centre National de la Recherche Scientifique), Daniel Clayton(The University of Sydney), Glenn F. King(The University of Queensland)
Cited by 14
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422
Evolution of separate predation- and defence-evoked venoms in carnivorous cone snails
|Nature Communications|2014|311